CI vs ELV
Cigna Group and Elevance Health, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CI | ELV |
|---|---|---|
| Revenue | $274.9B | $199.1B |
| Net income | $6.0B | $5.7B |
| Gross margin | 21.8% | 89.4% |
| Net margin | 2.3% | 2.8% |
| Return on equity | 14.4% | 13.3% |
| Diluted EPS | $22.18 | $25.21 |
| Dividend / share | $6.04 | · |
| Payout ratio | 27.0% | 27.0% |
| Free cash flow | · | $3.2B |
| Equity | $41.7B | $43.9B |
| Net debt / equity | 0.57× | 0.51× |
| Current ratio | 0.85× | 1.54× |
| Revenue CAGR 5y | 11.4% | 10.3% |
| Profit CAGR 5y | · | 4.4% |
CI bills 1.4× the revenue of ELV, and ELV keeps more of each dollar of revenue as profit (2.8% against 2.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | CI | ELV |
|---|---|---|
| FY2025 | $274.9B | $199.1B |
| FY2024 | $247.1B | $177.0B |
| FY2023 | $195.3B | $171.3B |
| FY2022 | $180.5B | $156.6B |
| FY2021 | $174.1B | $138.6B |
| FY2020 | $160.4B | $121.9B |
| FY2019 | $153.6B | $104.2B |
| FY2018 | $48.6B | $92.1B |
| FY2017 | $41.8B | $90.0B |
| FY2016 | $39.8B | $84.9B |
Bottom line
| Fiscal year | CI | ELV |
|---|---|---|
| FY2025 | $6.0B | $5.7B |
| FY2024 | $3.4B | $6.0B |
| FY2023 | $5.2B | $6.0B |
| FY2022 | $6.8B | $5.9B |
| FY2021 | $5.4B | $6.2B |
| FY2020 | $8.5B | $4.6B |
| FY2019 | $5.1B | $4.8B |
| FY2018 | $2.6B | $3.8B |
| FY2017 | $2.2B | $3.8B |
| FY2016 | $1.8B | $2.5B |
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$75,775,000,000 | CI |
| FY2024 | +$70,110,000,000 | CI |
| FY2023 | +$23,925,000,000 | CI |
| FY2022 | +$23,923,000,000 | CI |
| FY2021 | +$35,430,000,000 | CI |
| FY2020 | +$38,534,000,000 | CI |
| FY2019 | +$49,353,000,000 | CI |
| FY2018 | −$43,455,000,000 | ELV |
| FY2017 | −$48,234,000,000 | ELV |
| FY2016 | −$45,025,000,000 | ELV |
The higher-revenue side has changed between CI and ELV over this period. The gap has widened since the earliest year compared.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −0.6 pp | ELV |
| FY2024 | −1.8 pp | ELV |
| FY2023 | −0.7 pp | ELV |
| FY2022 | −0.0 pp | ELV |
| FY2021 | −1.3 pp | ELV |
| FY2020 | +1.5 pp | CI |
| FY2019 | −1.3 pp | ELV |
| FY2018 | +1.4 pp | CI |
| FY2017 | +1.1 pp | CI |
| FY2016 | +1.7 pp | CI |
The higher net margin has changed hands between CI and ELV over this period.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CI's net margin has been more volatile than ELV's over the 10 comparable fiscal years — 1.3 percentage points of standard deviation against 0.6.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CI and ELV over these 10 fiscal years — CI led in 4 and ELV in 6.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CI's return on equity has been more volatile than ELV's over the 10 comparable fiscal years — 2.9 percentage points of standard deviation against 2.0.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CI and ELV over these 10 fiscal years — CI led in 4 and ELV in 6.
10 of 19 comparable fiscal years — a year missing data on either side is not counted.